Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lexapro Shows Modest Sales Gains With Close Of 2004, Forest Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Sales of the antidepressant grew 3% sequentially in the quarter ended Dec. 31, but the gains were more than offset by a 50% decline in Celexa due to generic competition. Forest's better-than-expected quarterly earnings performance partially reflects a one-time, $30 mil. sale of the flu therapy Flumadine to the U.S. government.
Advertisement

Related Content

Forest Takes "Wait And See" Approach On Effect Of Antidepressant "Black Box" Labeling
Forest Takes "Wait And See" Approach On Effect Of Antidepressant "Black Box" Labeling
Forest Keeps Up Lexapro Detailing Pressure In Face Of Competition
Forest Keeps Up Lexapro Detailing Pressure In Face Of Competition
Celexa Generics Clear FDA
Forest Sees No Significant Impact From Antidepressant "Black Box" Warnings
Forest Sees No Significant Impact From Antidepressant "Black Box" Warnings

Topics

Advertisement
UsernamePublicRestriction

Register

PS061031

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel